Omeprazol Teva (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Teva, is a proton pump inhibitor presented as a oral medication for gastrointestinal acid‑related conditions. It reduces stomach acid production and is used in adults with reflux, ulcers and related disorders.

GNH USA supplies Omeprazol Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Teva is a proton‑pump inhibitor that acts on gastric acid secretion pathways. It is indicated for several acid‑related gastrointestinal conditions: - Gastroesophageal reflux disease (GERD): alleviates heart‑burn and esophageal irritation. - Peptic ulcer disease: promotes healing of gastric and duodenal ulcers. - Helicobacter pylori eradication regimens: used in combination with antibiotics to eradicate infection. - Zoll‑Zollinger‑Ellison syndrome (ZES): controls excessive acid production associated with gastrin‑producing tumors. - Acid‑related discomfort post‑operatively or from NSAID use: reduces risk of ulcer formation.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea or abdominal discomfort. - Flatulence or bloating. - Constipation. - Dry mouth.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis, angioedema). - Clostridioides difficile‑associated colitis. - Low magnesium levels (hypomagnesemia) with prolonged use. - Bone fracture risk with long‑term therapy. - Acute interstitial nephritis. - Liver enzyme elevation.

When prescribing Omeprazol Teva, clinicians should consider several safety aspects: - Renal or hepatic impairment: adjust monitoring as needed. - Long‑term use: assess need periodically to avoid unnecessary exposure. - Concomitant use with clopidogrel: evaluate benefit‑risk balance. - Pregnancy or lactation: use only if clearly needed. - Elderly patients: monitor for falls related to possible hypomagnesemia. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Omeprazole may affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir or other protease inhibitors: markedly reduced antiviral efficacy. - Warfarin: potential increase in INR, requiring closer monitoring.

Moderate Interactions (Monitor Closely): - Methotrexate: increased serum levels, especially with high‑dose regimens. - Digoxin: modest rise in serum concentration. - Diazepam: possible increase in sedation. - Iron supplements: decreased absorption, separate dosing by at least 2 h.